These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2004-004586-14||Double-blind, randomised, placebo-controlled, phase III study comparing the efficacy and safety of bilastine 20 mg once daily and cetirizine 10 mg for the treatment of allergic allergic rhinitis||2005-08-19||bad-data|
|Listed as ongoing, but also has a completion date||2006-001245-33||Double-blind, randomised, placebo-controlled, phase III study comparing the efficacy and safety of bilastine 20 mg once daily and levocetirizine 5 mg for the treatment of chronic idiopathic urticaria.||2007-08-07||bad-data|
|Not reported||2006-003004-19||A randomised, double-blind, four way cross-over, placebo controlled trial to evaluate the clinical efficacy, onset of action and drug activity at 22-26 hours following the drug intake of Bilastne 20 m...||2007-01-18||due-trials|
|Not reported||2009-012013-22||A Multicentre, International, Adaptive, Open-label, Repeated Administration Pharmacokinetic Study of Bilastine in Children from 2 to <12 Years of age with Allergic Rhinoconjunctivitis or Chronic Urtic...||2012-09-28||due-trials|
|Ongoing||2011-004830-32||Effects of bilastine on nasal volume after allergen-induced rhinitis in patients with allergic rhinitis||not-yet-due|
|Listed as ongoing, but also has a completion date||2012-003506-27||A multicenter, double-blind, randomized, placebo-controlled, parallel group study to evaluate the safety and tolerability of 10 mg once daily bilastine in children from 2 to 11 years of age with eith...||2014-07-11||bad-data|
|Completed, but no date||2015-000790-13||A single-centre, randomized, double-blind, crossover, single-dose clinical trial to compare bilastine, desloratadine, rupatadine and placebo in the suppression of wheal and flare induced by intraderma...||bad-data|
|Not reported||2016-001505-17||An exploratory study to evaluate the efficacy and safety of bilastine in reducing pruritus in patients with chronic spontaneous urticaria and other skin diseases.||2017-03-30||due-trials|
|Ongoing||2017-004028-31||Effect of the administration of different Hidroferol® Soft Gelatine Capsules (calcifediol) and cholecalciferol (Dibase®) regimens on 25(OH)D levels and markers of bone remodelling in postmenopausal wo...||not-yet-due|
|Completed, report not yet due||2018-000913-19||Phase IV, single centre, randomised, open-label, two-period, two-way crossover clinical trial to assess the efficacy of Bilastine 20mg in the suppression of wheal and flare induced by intradermal hist...||2018-06-30||not-yet-due|
|Ongoing||2018-002248-95||Multi-centre, randomised, double blind, placebo-controlled, parallel, phase III study to assess the safety, tolerability and efficacy of bilastine ophthalmic solution 0.6% in adults||not-yet-due|
|Ongoing||2018-003940-21||A pilot, multicentre, single-blind, randomized, placebo-controlled, parallel-group clinical trial, to assess the safety of Bilastine treatment regarding psychomotor performance using a virtual reality...||not-yet-due|